2013 Fiscal Year Final Research Report
Treatment of metastatic carcinoma using non-viable bacterial BCG formulation
| Project/Area Number |
23592323
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Urology
|
|---|
| Research Institution | University of Tsukuba |
|---|
Principal Investigator |
KAWAI Kouji 筑波大学, 医学医療系, 講師 (90272195)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
MIYAZAKI Jun 筑波大学, 医学医療系, 准教授 (10550246)
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Keywords | 泌尿器科 / ビーシージー / 癌免疫 / リポソーム |
|---|
| Research Abstract |
Mycobacteriuma bovis bacillus Calmette-Guerin (BCG) intravesical therapy is a cancer immunotherapy which has been established. However, it is not applicable to metastatic lesion because of side effects caused by live bacteria. We have developed a small-diameter particles of liposome BCG-CWS (cell wall skeleton) with a view to industrialization.
|
Research Products
(2 results)
